A gene therapy, referred to as CAR7, is showing promise in treating a type of blood cancer. The therapy, which involves editing or modifying immune cells, has been reported to have potential benefits for patients with aggressive forms of the disease. However, the specific details and applications of the therapy, including the types of cancer it may be effective against, are not consistently reported across different sources.